Urokinase-Type Plasminogen Activator Expression Correlates With Tumor Angiogenesis and Poor Outcome in Gastric Cancer

Cancer Science - United States
doi 10.1111/j.1349-7006.2003.tb01350.x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Overexpression of Forkhead Box M1 and Urokinase‑type Plasminogen Activator in Gastric Cancer Is Associated With Cancer Progression and Poor Prognosis

Oncology Letters
Cancer ResearchOncology
2017English

Urokinase Type Plasminogen Activator Receptor Expression in Colorectal Neoplasms

Gut
Gastroenterology
1998English

[Corrigendum] High Expression of RELM-α Correlates With Poor Prognosis and Promotes Angiogenesis in Gastric Cancer

Oncology Reports
MedicineCancer ResearchOncology
2018English

Abnormal Expression of Paxillin Correlates With Tumor Progression and Poor Survival in Patients With Gastric Cancer

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2013English

Downregulation of miR-193b Contributes to Enhance Urokinase-Type Plasminogen Activator (uPA) Expression and Tumor Progression and Invasion in Human Breast Cancer

Oncogene
Cancer ResearchGeneticsMolecular Biology
2009English

Imaging Active Urokinase Plasminogen Activator in Prostate Cancer

Cancer Research
Cancer ResearchOncology
2015English

Soluble Urokinase-Type Plasminogen Activator Receptor in Black Americans With CKD

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2018English

Urokinase-Type Plasminogen Activator (PLAU; uPA); Thrombin (F2)

Science-Business eXchange
2010English

Role of Plasminogen Activator-Plasmin System in Tumor Angiogenesis

Cellular and Molecular Life Sciences
Molecular NeuroscienceMolecular MedicineCell BiologyMolecular BiologyPharmacologyCellular
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy